Rybelsus (semaglutide tablets), the first GLP-1 in a tablet approved in the US [press release]
These requirements result in higher compliance costs and sometimes lead to market entry delays or restrictions for smaller manufacturers
If you experience any suspected side effects from any medication, report them through the MHRA Yellow Card scheme
B12 is notoriously hard to absorb through the gut, especially as you get older or if you have certain digestive issues
Interestingly, GFR remained increased even 14 days after cessation of rhIGF-1 therapy compared to placebo-treated controls, suggesting that rhIGF-1 resulted in renal hypertrophy, since the hemodynamic effects should have worn off within 14 days of cessation
For a 200-pound person, that's a 30-pound loss